Harbour Capital Advisors, LLC Biogen Inc. Transaction History

Harbour Capital Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 05, 2024	BUY	$222.59 - $267.94 $228,154 - $274,638	1,025 New	1,025 $265,000
Q2 2020 Jul 21, 2020	SELL	$258.66 - $342.55 $166,318 - $220,259	-643 Closed	0 $0
Q1 2020 Apr 08, 2020	BUY	$268.85 - $341.04 $172,870 - $219,288	643 New	643 $203,000
Q3 2019 Oct 30, 2019	SELL	$217.44 - $243.88 $503,808 - $565,069	-2,317 Closed	0 $0
Q2 2019 Jul 10, 2019	SELL	$219.29 - $241.72 $483,753 - $533,234	-2,206 Reduced 48.77%	2,317 $542,000
Q1 2019 Apr 24, 2019	BUY	$216.71 - $338.96 $116,806 - $182,699	539 Added 13.53%	4,523 $1.07 Million
Q4 2018 Jan 23, 2019	BUY	$278.5 - $352.75 $149,554 - $189,426	537 Added 15.58%	3,984 $1.2 Million
Q3 2018 Nov 07, 2018	BUY	$293.51 - $383.83 $199,293 - $260,620	679 Added 24.53%	3,447 $1.22 Million
Q2 2018 Jul 11, 2018	BUY	$257.52 - $306.91 $324,475 - $386,706	1,260 Added 83.55%	2,768 $819,000
Q1 2018 Apr 18, 2018	BUY	$260.13 - $367.91 $168,304 - $238,037	647 Added 75.15%	1,508 $413,000
Q3 2017 Nov 08, 2017	BUY	$281.15 - $329.69 $242,070 - $283,863	861	861 $270,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Harbour Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Harbour Capital Advisors, LLC with notifications on news.